Charakterisierung von DNA-Methylierungs-Biomarkern für das Harnblasenkarzinom

Bladder carcinoma is the most common malignancy of the urinary tract. Approximately 75-85% of patients present with a disease that is confined to the mucosa (stage Ta, carcinoma in situ) or submucosa (stage T1). The stratification of patients to low-, intermediate- and high-risk groups represents the cornerstone for the indication of adjuvant and follow-up treatment. Owing to the high recurrence rate of bladder tumors, a surveillance protocol is recommended to all patients. Currently, the combination of cystoscopy, imaging and urinary cytology represent the follow-up. A systematic review of the recent English literature on follow-up procedures of non-muscle-invasive bladder cancer is performed. The authors review the existing follow-up procedures, with a focus on novel molecular-targeted approaches. At the present time, the additional use and utility of urine-based molecular markers in the follow-up of patients remains unclear and we have to rely on cystoscopic evaluation adapted to risk group classification.

show abstract

Follow-up procedures for non-muscle-invasive bladder cancer: an update

Anastasiadis

Cordeiro

Bus

et al. 2012

Expert Review of Anticancer Therapy

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Charakterisierung von DNA-Methylierungs-Biomarkern für das Harnblasenkarzinom

Abstract: P. Antony und M. Rose trugen zu gleichen Teilen als Erstautoren zu dieser Studie bei.

Cited by 1 publication

References 22 publications

Follow-up procedures for non-muscle-invasive bladder cancer: an update

Follow-up procedures for non-muscle-invasive bladder cancer: an update

Contact Info

Product

Resources

About